港股异动｜昭衍新药涨超4% 参投产业基金完成备案

Group 1 - The core point of the article is that Zhaoyan New Drug (6127.HK) has seen a 4.17% increase in its stock price, reaching HKD 23.46, with a market capitalization of HKD 17.57 billion [2] - The company has announced a collaboration with professional investment institutions to establish an industrial fund [2] - Zhaoyan New Drug has received notification from China Merchants Capital Management (Beijing) Co., Ltd. that the fund has completed the private investment fund registration with the Asset Management Association of China and has obtained the Private Investment Fund Registration Certificate [2]